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Abstract Inducible expression of the mammalian glial cell
glutamate transporter GLT-1 has been established in a CHO cell
line selected for low endogenous Na+-dependent glutamate
uptake by [3H]aspartate suicide selection. Culturing the cells in
doxycycline-containing medium, to activate GLT-1 expression
via the Tet-On system, increased uptake of the GLT-1 substrate
D-aspartate 280-fold, and increased cell size. Applying glutamate
to whole-cell clamped, doxycycline-treated cells evoked a
transporter-mediated current with characteristics appropriate
for GLT-1. This cell line provides a useful tool for further
examination of the electrical, biochemical and pharmacological
properties of GLT-1, the most abundant glutamate transporter in
the brain.
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1. Introduction
Glutamate uptake into neurones and glial cells of the cen-
tral nervous system is important for helping to terminate the
postsynaptic action of neurotransmitter glutamate, and for
preventing the extracellular glutamate concentration from ris-
ing to neurotoxic levels [1^6]. In addition, glutamate release
by reversal of the uptake process may underlie the death of
neurones during brain anoxia [7]. Five distinct sodium-de-
pendent glutamate transporters, GLAST, GLT-1, EAAC1,
EAAT4 and EAAT5, have been cloned from mammals [8^
12]. GLT-1 is the most abundant transporter [13], and repre-
sents about 1% of all brain protein [14]. The properties of
these transporters have mainly been investigated by expressing
them heterologously in toad oocytes.
It would be useful to have mammalian cell lines expressing
the di¡erent glutamate transporters, because the transporters’
properties might di¡er in mammalian and amphibian cells.
Furthermore, mammalian cells are generally suitable for
whole-cell clamping, which allows monitoring of transporter
activity as a membrane current [15] while controlling the in-
tracellular contents by dialysis with the pipette solution, facil-
itating investigation of the ionic movements driving glutamate
transport [16]. Ideally, expression of glutamate transporters
would be best done in a cell line with little endogenous glu-
tamate transport, to improve the signal to noise ratio for
investigations of the expressed transporter. The GLAST
transporter has been stably expressed in HEK293 cells [17],
but these cells might also express endogenous glutamate trans-
porters, and glutamate apparently still evoked a current in
these cells even in the absence of extracellular sodium suggest-
ing the presence of a glutamate-activated current component
in addition to the Na-dependent GLAST.
We therefore attempted to produce a cell line expressing
GLT-1 but no other Na-dependent glutamate transporters
or glutamate-activated currents, taking advantage of the ex-
istence of mutant CHO cell lines lacking Na-dependent glu-
tamate transport [18,19]. These cells were isolated by suicide
selection with [3H]aspartate: aspartate is a substrate for Na-
dependent glutamate transporters, and uptake of tritiated as-
partate, followed by frozen storage to allow time for radiation
damage to accumulate, results in an increase in the proportion
of cells lacking Na-dependent uptake.
2. Materials and methods
2.1. Choice of cell line
The CHO cell line chosen for this work was the mutant Dd-B7,
which maintains low endogenous Na-dependent glutamate/aspartate
transport for more than 70 cell doublings in long-term culture [19].
Although GLT-1 could be expressed transiently in Dd-B7 cells (Igo
and Ash, unpublished), clones maintaining stable expression were not
obtained. We therefore turned to inducible expression of GLT-1, in
the hope that the cells would tolerate this better.
2.2. Transfection and cell selection
Dd-B7 cells were cultured in DMEM/Ham’s F12 cell culture me-
dium (Gibco 21331) supplemented with 2.5 mM L-glutamine, non-
essential amino acids (Gibco 11140-035, diluted 1:200), 5% newborn
calf serum and 5% horse serum. The cells were kept at 37‡C in a
humidi¢ed incubator with 5% CO2. Before the cells grew to con£u-
ence, they were co-transfected using Transfectam (Promega) with the
pTet-On regulator plasmid (Clontech) and with rat GLT-1 cDNA
(directionally inserted in the pTet response element plasmid using
the EcoRI and XbaI cloning sites [20,21]). The GLT-1 insert included
the 1.72 kbp coding sequence as well as 0.1 kbp of 5P and 2.0 kbp of
3P non-coding sequence.
Cells were grown for 14 h, replated at low density, and then grown
for another 24 h, before selecting successfully transfected cells : pTet-
On contains a neomycin resistance gene, allowing selection of trans-
fected cells with the neomycin analogue geneticin (0.4 mg/ml). Ten to
twelve days after starting culture in the geneticin-containing medium,
geneticin-resistant clones were transferred to separate wells. From
these resulting clonal cell lines, a radiotracing screen with D-
[3H]aspartate was used to select the cell line with the highest D-aspar-
tate uptake induced by doxycycline (2 Wg/ml), which should bind to
the reverse Tet-responsive transcriptional activator (rtTA, encoded by
the pTet-On regulator plasmid) allowing rtTA to activate expression
of GLT-1 [20]. To do this, each clone was split, with an equal number
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of cells plated into two 1.9 cm2 wells, allowing the background level
of aspartate uptake and the uptake induced by doxycycline to be
measured separately. Uptake was measured using external solution
containing (mM) NaCl 137, K2HPO4 0.7, HEPES 10, MgCl2 1, CaCl2
1, pH 7.4. The cells were washed with 2U1 ml of this solution, then
incubated (at 26‡C) in 0.4 ml of this solution containing 0.2 WM D-
[3H]aspartate for 5 min, and ¢nally washed with 3U1 ml of the ex-
ternal solution, before lysing with 1% SDS and scintillation-counting
the accumulated radioactivity. Estimates of substrate in£ux based on
whole-cell clamp measurements of the uptake current per cell sug-
gested that the intracellular D-aspartate concentrate would increase
by 6 100 WM over the 5 min incubation period. The selected cell
line was then subcloned one more time to ensure it was clonal, and
selection pressure was maintained subsequently using 0.2 mg/ml ge-
neticin.
2.3. Whole-cell clamping
Cells were detached from their culture wells by washing with a
solution containing (mM) NaCl 137, K2HPO4 0.7, HEPES 10,
Na2EDTA 0.5, pH 7.4, and replated onto a glass bottomed chamber
which had been half-¢lled with external solution (see below, the diva-
lent ions in this solution allow the cells to adhere to the chamber) on a
¢xed stage microscope. Cells were clamped with electrodes ¢lled with
solution containing (mM) KCl 140, CaCl2 0.5, Na2EGTA 5, HEPES
10, MgCl2 2, Na2ATP 1, pH 7.0, in external solution containing (mM)
NaCl 140, KCl 2.5, HEPES 10, MgCl2 2, CaCl2 2.5, Na2HPO4 1,
glucose 10, pH 7.4. Electrode resistance was approximately 5 M6
when immersed in the external solution, 2 G6 in cell-attached mode
and the series resistance in whole-cell mode was around 10 M6. Series
resistance voltage errors were negligible (6 2 mV). The cells are ap-
proximately spherical after replating as described above, so voltage
non-uniformity in the cell is also negligible. The electrode junction
potential was corrected for. To correlate transporter current with
the membrane area of the cell studied, cell diameter was measured
from the image of the cell on a TV screen linked to a camera on the
microscope.
3. Results
Activity of glutamate transporters was initially assayed by
comparing the uptake of D-[3H]aspartate (0.2 WM in the ex-
tracellular solution) in cells cultured in doxycycline with that
in cells cultured for the same amount of time in the absence of
doxycycline. Uptake was low in the absence of doxycycline
(Fig. 1, open symbols), and may re£ect transport by mecha-
nisms other than Na-dependent transporters. With doxycy-
cline added to the culture medium, however, D-aspartate up-
take was dramatically increased within 24 h of adding the
doxycycline, and reached a maximum after 36^48 h (Fig. 1).
The greatest increase of uptake was produced by 2 Wg/ml
doxycycline, with a similar but slightly smaller increase pro-
duced by 6 Wg/ml doxycycline, and about 25% less increase
with 0.6 Wg/ml doxycycline. For the cell batch studied in Fig.
1, the maximum upregulation of uptake (normalised by cell
protein) produced by doxycycline was 280-fold. In two other
batches of cells from the same selected line similar large in-
creases were seen, by factors (not normalised by cell protein)
of 117 at 24 h in one batch, and of 269 at 48 h in the other
batch, in 2 Wg/ml doxycycline.
A feature of the cells treated with doxycycline was that they
appeared larger than those not treated with doxycycline. This
was noticeable when the cells were growing in culture wells,
and was quanti¢ed after replating the cells (see Section 2) to
convert them to a conveniently measurable spherical shape
(Fig. 2): their mean radius increased from 6.8 to 8.5 Wm
(see Fig. 2 legend), corresponding to a doubling of vol-
ume. Although this could be a non-speci¢c e¡ect of doxycy-
cline, it is plausible that this volume increase was promoted
by the upregulation of glutamate transport, as discussed
below.
Previous work has shown that the Na-dependent gluta-
mate transporters are electrogenic, so that transporter activity
can be monitored as a membrane current [15]. To examine the
doxycycline-induced transporter activity at a single cell level,
we whole-cell clamped cells which had been treated with 2 Wg/
ml doxycycline for 30^48 h. Glutamate evoked an inward
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Fig. 1. Induction of glutamate/aspartate transporter expression by
doxycycline. Data points show uptake of radioactive D-aspartate
(arbitrary units, normalised by protein content in parallel wells of
cells) in cells treated (¢lled symbols) or not treated (open symbols)
with doxycycline. Doxycycline was added at time zero to the treated
cells. The di¡erent concentrations of doxycycline used are shown by
each curve.
Fig. 2. Histograms showing the frequency distribution of radii of
cells treated (A) or not treated (B) with 2 Wg/ml doxycycline for 48
h. Doxycycline-treated cells had a mean radius of 8.52 þ 0.11 Wm
(mean þ S.E.M., n = 300), while non-treated cells had a mean radius
of 6.75 þ 0.08 Wm (n = 200), i.e. di¡erent with P6 10327 on Student’s
2-tailed t-test.
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current (Fig. 3A) that was reduced by kainate, which is a
blocker speci¢c for GLT-1 and its human homologue
EAAT2 [9,22]. The response to 50 WM glutamate was reduced
by 63 þ 3% (mean þ S.E.M., 4 cells) by 200 WM kainate. With
no sodium in the external solution (replaced by choline) glu-
tamate evoked no current (6 cells, data not shown), showing
both that the transporter is Na-dependent and that there are
no other glutamate-gated currents in these cells. A detailed
electrophysiological analysis of the properties of GLT-1 will
be published elsewhere.
We gained the impression that the cells showing the largest
glutamate uptake currents were the largest diameter cells. To
determine whether this was simply because larger cells have
more surface area, we plotted the current evoked by a satu-
rating dose of glutamate as a function of the measured radius
of the cell (Fig. 3B), and also plotted current per area of the
cell as a function of radius (Fig. 3C). The current was too
small to be reliably detected for cells below 6 Wm in radius.
Above this size, the current increased with radius, but the
current per membrane area was roughly constant within the
scatter of the data (Fig. 3C). The smooth line through Fig. 3B
increases with the square of the radius, as predicted if current
is proportional to area (best-¢tting a curve proportional to
radiusn gave n = 2.4 þ 0.6). Cells not treated with doxycycline
rarely showed any current change in response to glutamate
(open symbols in Fig. 3B), no matter what their radius, and in
the two cells which appeared to show a small response it was
at the limit of detection.
4. Discussion
The results reported here establish the feasibility of control-
ling glutamate transporter expression in mammalian cells us-
ing the Tet-On system. The cell line we describe should prove
useful for further investigation of the properties of GLT-1,
and the strategy used in its construction may be useful for
expressing other transporters. By combining suicide selection
of the parent CHO cell line, using radioactive substrate to
select for mutants with low endogenous transport [18,19],
with inducible expression of the transporter under study, we
have constructed a cell line with very little background gluta-
mate transport in which the e¡ects of transporter expression
can be studied by comparing cells treated and not treated with
doxycycline.
A notable e¡ect of treating cells with doxycycline was that
their size was increased (Fig. 2). A plausible explanation of
this is that doxycycline-evoked upregulation of GLT-1 accel-
erates uptake of glutamate and aspartate from the culture
medium (which contains 50 WM glutamate and 100 WM aspar-
tate), which would provide amino acids for protein synthesis,
feed into the citric acid cycle, and also help to establish the
high intracellular glutamate concentration which is needed to
drive uptake of cystine, a precursor of the antioxidant gluta-
thione, by the glutamate/cystine exchanger [19,23]. It is also
possible that expression of GLT-1 increases the osmotic load
on the cells, leading to swelling, or retards cell cycle progres-
sion, allowing cells to grow larger before mitosis.
We observed, in whole-cell clamp experiments, that there is
more glutamate transport in larger cells (Fig. 3), but a similar
density per area of the cell membrane. Coordinated cellular
control of transporter expression might be expected in cells
expressing transporters normally, but the random incorpora-
tion of the GLT-1 cDNA into the genome of our host cell line
may preclude normal control of its expression by upstream
promoters. At present it remains uncertain, therefore, whether
there is an internal cellular mechanism which automatically
triggers more transporter expression as cells grow larger, or
whether the causality is the other way round, with cells which
happen to express more glutamate/aspartate uptake being able
to grow larger.
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pendent of radius, with k = 0.0052 pA/(Wm)2, the mean value of I/
4Zr2 in all the cells. C: Uptake current/cell area (I/4Zr2) from B
plotted as a function of cell radius.
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